Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family.

× No keyword cloud information.

19 in total

1. Cutaneous markers of internal disease.

Authors: R R Forsey; P M Reardon
Journal: Can Fam Physician Date: 1982-08 Impact factor: 3.275

Review 2. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.

Authors: M Donaghy; R H King; R O McKeran; M S Schwartz; P K Thomas
Journal: J Neurol Date: 1990-06 Impact factor: 4.849

3. Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.

Authors: Rgia A Othman; Semone B Myrie; David Mymin; Jean-Baptiste Roullet; Andrea E DeBarber; Robert D Steiner; Peter J H Jones
Journal: J Pediatr Date: 2017-06-16 Impact factor: 4.406

4. Cerebrotendinous xanthomatosis.

Authors: A S Truswell; P J Pfister
Journal: Br Med J Date: 1972-02-05

5. Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

Authors: Y Hokezu; M Kuriyama; R Kubota; M Nakagawa; J Fujiyama; M Osame
Journal: Neuroradiology Date: 1992 Impact factor: 2.804

6. Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.

Authors: Chiung-Chih Chang; Chun-Chung Lui; Jiun-Jie Wang; Shu-Hua Huang; Cheng-Hsien Lu; Ching Chen; Chih-Feng Chen; Min-Chien Tu; Chi-Wei Huang; Wen-Neng Chang
Journal: BMC Neurol Date: 2010-07-06 Impact factor: 2.474

Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family.

1. Cutaneous markers of internal disease.

Review 2. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.

3. Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.

4. Cerebrotendinous xanthomatosis.

5. Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients.

6. Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.

7. An improved radiological method for the evaluation of Achilles tendon xanthomatosis.

8. De- and remyelination and onion bulb in cerebrotendinous xanthomatosis.

9. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.

10. Abnormal high density lipoproteins in cerebrotendinous xanthomatosis.